How is capmatinib associated with a decrease in blood pressure?

Capmatinib, as an innovative targeted therapy, brings new treatment opportunities to patients with non-small cell lung cancer (NSCLC) with MET exon 14 skipping mutations. However, while enjoying its anti-cancer effects, patients are also highly alert to possible physiological changes, among which changes in blood pressure are a focus of much attention.

In the existing medical research and literature, direct evidence that capmatinib can cause blood pressure reduction is still scarce. However, it must be recognized that the effects of any drug in the human body are complex and changeable, and may trigger a series of physiological reactions, including fluctuations in blood pressure. Therefore, the specific effect of capmatinib on blood pressure remains an unclarified issue, and more clinical practice data are needed to reveal the truth.

If patients notice unusual fluctuations in blood pressure, whether it is rising or falling, while taking capmatinib, they should contact their attending physician immediately. Because changes in blood pressure may not only be related to the drug itself, but may also be affected by multiple factors such as the patient's original health condition, other drugs taken at the same time, and daily habits.

In addition, it is worth noting that the use of capmatinib may also be associated with some adverse reactions, such as nausea, vomiting, diarrhea, and fatigue. Therefore, patients should always pay attention to their own body reactions during medication and provide timely feedback to the doctor.

In summary, there is currently no clear conclusion on whether capmatinib can cause a decrease in blood pressure. Considering that each patient's physical condition and drug response are different, the best way to deal with any questions or discomfort during medication is to communicate with the attending physician in a timely manner to obtain the most professional and personalized treatment advice.

It is understood that capmatinib is currently available in overseas markets. The price of the original drug is relatively high, while generic drugs provide a more economical option, with each box selling for about three to four thousand.